An escalating dose study to assess the safety, tolerability and immunogenicity of a Herpes Simplex Virus DNA vaccine, COR-1

This paper describes a single site, open-label Phase I clinical trial evaluating the safety, tolerability and immunogenicity in healthy volunteers of a herpes simplex polynucleotide vaccine that has previously been shown to enhance immunogenicity and protect against lethal herpes simplex virus type...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutton, Julie L., Woo, Wai-Ping, Chandra, Janin, Xu, Yan, Li, Bo, Finlayson, Neil, Griffin, Paul, Frazer, Ian H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215501/
https://www.ncbi.nlm.nih.gov/pubmed/27580249
http://dx.doi.org/10.1080/21645515.2016.1221872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215501/
https://www.ncbi.nlm.nih.gov/pubmed/27580249
http://dx.doi.org/10.1080/21645515.2016.1221872

Ejemplares similares